A detailed history of Jane Street Group, LLC transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Jane Street Group, LLC holds 64,636 shares of NRSN stock, worth $70,453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,636
Holding current value
$70,453
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.86 - $1.36 $55,586 - $87,904
64,636 New
64,636 $77,000
Q2 2022

Aug 16, 2022

BUY
$1.24 - $3.76 $41,851 - $126,903
33,751 Added 77.59%
77,249 $261,000
Q1 2022

May 17, 2022

BUY
$1.33 - $6.23 $57,852 - $270,992
43,498 New
43,498 $173,000

Others Institutions Holding NRSN

About NeuroSense Therapeutics Ltd.


  • Ticker NRSN
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,674,000
  • Market Cap $12.7M
More about NRSN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.